Trials / Completed
CompletedNCT00516672
Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors
A Phase I, Open-Label, Multiple Dose of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a two part phase I study in Japanese patients that will determine the safety, tolerability and pharmacokinetics of pazopanib monotherapy and of pazopanib in combination with lapatinib.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pazopanib | Pazopanib oral tablet |
| DRUG | Lapatinib | Lapatinib oral tablet |
Timeline
- Start date
- 2007-09-10
- Primary completion
- 2010-08-30
- Completion
- 2015-10-14
- First posted
- 2007-08-15
- Last updated
- 2017-11-13
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00516672. Inclusion in this directory is not an endorsement.